Matthew J. Krasin
- Genetics top 0.5%
- Glioma Diagnosis and Treatment 23
- Neurology top 0.5%
- Neuroblastoma Research and Treatments 28
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment 51
- Radiation Therapy and Dosimetry 18
-
- Childhood Cancer Survivors' Quality of Life 38
-
- Lymphoma Diagnosis and Treatment 28
-
- Advanced Radiotherapy Techniques 30
-
- Acute Lymphoblastic Leukemia research 23
- Co-authors
- Melissa M. HudsonThomas E. MerchantLarry E. KunCatherine A. BillupsAndrew M. DavidoffLeslie L. RobisonAmar GajjarSheri L. Spunt
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Matthew J. Krasin
190 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 121
- Genetics 1.2k
- Neurology 1.3k
- Pulmonary and Respiratory Medicine 2.6k
- Pediatrics, Perinatology and Child Health 1.5k
- Pathology and Forensic Medicine 1.0k
Countries citing papers authored by Matthew J. Krasin
This map shows the geographic impact of Matthew J. Krasin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Krasin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Krasin more than expected).
Fields of papers citing papers by Matthew J. Krasin
This network shows the impact of papers produced by Matthew J. Krasin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Krasin. The network helps show where Matthew J. Krasin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew J. Krasin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 16 | |
| 13 | 2019 | 3 | |
| 14 | 2018 | 18 | |
| 15 | 2016 | 5 | |
| 16 | 2013 | 37 | |
| 17 | 2013 | 243 | |
| 18 | 2007 | 86 | |
| 19 | 2006 | 50 | |
| 20 | 2003 | 52 |
About Matthew J. Krasin
Matthew J. Krasin is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Neurology, having authored 200 papers that have together received 5.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (51 papers), Childhood Cancer Survivors' Quality of Life (38 papers), Advanced Radiotherapy Techniques (30 papers), Neuroblastoma Research and Treatments (28 papers), Lymphoma Diagnosis and Treatment (28 papers), Glioma Diagnosis and Treatment (23 papers), Acute Lymphoblastic Leukemia research (23 papers) and Radiation Therapy and Dosimetry (18 papers). The work is most often cited by research in Genetics (1.2k citations), Neurology (1.3k citations) and Pulmonary and Respiratory Medicine (2.6k citations). Matthew J. Krasin has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Melissa M. Hudson, Thomas E. Merchant, Larry E. Kun, Catherine A. Billups, Andrew M. Davidoff, Leslie L. Robison, Amar Gajjar, Sheri L. Spunt, Deo Kumar Srivastava and Kirsten K. Ness. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.